Singh Abhishek, Singh Parul, Sahni Kamal, Shukla Preety, Shukla Vikas, Pant Nirdosh K
Department of Radiation and Clinical Oncology, Swami Rama Cancer Institute, UFHT Medical College, Haldwani, 263139, India.
J Med Case Rep. 2010 Jun 19;4:185. doi: 10.1186/1752-1947-4-185.
Metastatic tumors are the most common intra-ocular malignancies and choroid is by far the most common site for intra-ocular malignancies. Multiple foci are usually involved, and bilateral involvement is frequently seen. The primary sites for choroidal metastasis in decreasing order and by gender are: breast, lung, unknown primary, gastrointestinal and pancreas, skin melanoma and other rare sources in females, and lung, unknown primary, gastrointestinal and pancreas, prostate, kidney, skin melanoma and other rare sources in males. Available treatment options are external beam radiotherapy and plaque radiotherapy, while new methods like surgical resection, transpupillary thermotherapy and intravitreal chemotherapy offer promises for the future. The use of chemotherapy alone for choroidal metastases is not widely reported.
We report the case of a 50-year-old Indian man who had a unilateral solitary lesion in his right eye. He was found to have an adenocarcinoma of the lung with choroidal metastasis as the first presenting sign. There were no findings of metastasis involving his contralateral eye. He was administered chemotherapy based on gemcitabine and carboplatin. He had significant progressive subjective and objective improvement since his first chemotherapy. His current best corrected visual acuity is 20/60 after three cycles of chemotherapy.
Chemotherapy alone can be used as an effective mode of treatment in patients who have primary tumors that respond to chemotherapy.
转移性肿瘤是最常见的眼内恶性肿瘤,脉络膜是迄今为止眼内恶性肿瘤最常见的部位。通常累及多个病灶,双侧受累也很常见。脉络膜转移的原发部位按女性递减顺序依次为:乳腺、肺、原发灶不明、胃肠道和胰腺、皮肤黑色素瘤及其他罕见来源;男性依次为:肺、原发灶不明、胃肠道和胰腺、前列腺、肾、皮肤黑色素瘤及其他罕见来源。现有的治疗选择包括外照射放疗和敷贴放疗,而手术切除、经瞳孔温热疗法和玻璃体内化疗等新方法为未来带来了希望。单独使用化疗治疗脉络膜转移的报道并不广泛。
我们报告了一例50岁的印度男性病例,其右眼有一个单侧孤立性病变。他被发现患有肺腺癌,脉络膜转移是首个出现的症状。未发现对侧眼有转移迹象。他接受了基于吉西他滨和顺铂的化疗。自首次化疗以来,他在主观和客观上都有显著的改善。经过三个周期的化疗后,他目前的最佳矫正视力为20/60。
对于原发肿瘤对化疗有反应的患者,单独化疗可作为一种有效的治疗方式。